Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris. - Wikidata - wikimedia - TriplyDB

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.

http://www.wikidata.org/entity/Q37599625

about

CUPID: a protocol of a randomised controlled trial to identify characteristics of similar Chinese patent medicines Efficacy of Ligustrazine Injection as Adjunctive Therapy for Angina Pectoris: A Systematic Review and Meta-Analysis.

P2860

Q34589260-EDE5190E-C815-417A-9AD5-73CF76E97101 Q35854874-C5D47571-F819-4B53-BBFF-4F0C9EF38508

P2860

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.

http://www.wikidata.org/entity/Q37599625

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.

@en

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.

@nl

type

label

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.

@en

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.

@nl

prefLabel

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.

@en

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.

@nl

P1433

Q37599625-2A6D7D90-B9A1-4308-A044-FE85A61B757A

P1476

Q37599625-CFACB090-935F-4664-A2F3-69C7FA2448FA

P2093

Q37599625-1B76D6A6-BD3F-4D2D-85BE-1424DBF83817

Q37599625-BD253F0E-9F59-4655-9229-9AE4761F1E67

P2860

Q37599625-0C41E213-42FD-4D9D-A7C8-F7DAFCDEDE1B

Q37599625-160F6C9C-A061-4E0C-AF71-DEEA1899DC43

Q37599625-1D780408-7F0A-4A15-80AC-12FBB601A909

Q37599625-1ECFCFF5-4311-45FA-A80D-1615AB95C178

Q37599625-228FD907-6EEB-4CED-A48B-B39E5E58699D

Q37599625-2C664255-DF58-460A-8740-EE31DBDEA7EE

Q37599625-3321F5CA-66D2-48E2-A541-28727AE69453

Q37599625-3365CED5-0B8E-4153-A814-EBC310ADAC7F

Q37599625-390BC0CE-753B-44EF-A4A0-A02499EDE191

Q37599625-42A68AF9-13BC-4F1B-B999-B637890772CE

P304

Q37599625-A94BBB8B-C1BF-4EC3-9267-DDBE31CF5B79

P31

Q37599625-09AC107B-F41E-4301-A7F1-1D00A23C36AA

P356

Q37599625-281188FB-4905-456D-AC6B-DAA85710DCE9

P433

Q37599625-EC5A518C-8A91-4408-80AC-F46C506EC3C1

P478

Q37599625-3C919294-B5B9-4178-92A8-C5D2A738DB5B

P50

Q37599625-EDB21EC7-921F-456B-B6DE-B28F1A142082

P577

Q37599625-0EBAD632-B9A1-4BC5-8B32-A70E1B3A9009

P698

Q37599625-38892DCC-BB87-4E79-A8FE-2BC9AD3E39C1

P932

Q37599625-3F33152B-2ABE-41F0-858B-96087CACE65B

P356

P1433

Clinical medicine insights. Therapeutics

P1476

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris

@en

P2093

Amadou K S Camara

http://www.w3.org/2001/XMLSchema#string

Mohammed Aldakkak

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association

Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action

Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity

The mitochondrial permeability transition pore and its role in cell death

Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.

Cariporide (HOE642), a selective Na+-H+ exchange inhibitor, inhibits the mitochondrial death pathway.

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, a

The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.

P304

1-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CMT.S7824

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24574825

http://www.w3.org/2001/XMLSchema#string

P932

3932785

http://www.w3.org/2001/XMLSchema#string